VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISHL HL Update 2021 | ctDNA and liquid biopsies in HL

Sven Borchmann, MD, University of Cologne, Cologne, Germany, touches on the potential of circulating tumor DNA (ctDNA) and liquid biopsies as tools for monitoring response to treatment in patients with Hodgkin lymphoma (HL), as well as the next steps to better understand the role of these tools in stratifying patients response. This interview took place at the Update on Hodgkin Lymphoma 2021, a Virtual ISHL event.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter